IDiyas

For the Inventor, By the Inventor

Parma, Italy

Carmelida Capaldi

USPTO Granted Patents = 28 


 

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:

goldMedal28 out of 328 
 
Chiesi Farmaceutici S.p.a.
 patents

Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):
1. 10364245 - Kinase inhibitors (2019-07-30),
2. 10172830 - Pyrazolone compounds having human neutrophil elastase inhibitory properties (2019-01-08),
3. 10117860 - Aminoester derivatives (2018-11-06),
4. 10100050 - Kinase inhibitors (2018-10-16),
5. 10023558 - Compounds (2018-07-17),
6. 9994565 - Kinase inhibitors (2018-06-12),
7. 9944612 - 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors (2018-04-17),
8. 9931327 - Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors (2018-04-03),
9. 9890169 - Triazolinone compounds as HNE inhibitors (2018-02-13),
10. 9868740 - Pyrimidinone compounds which are HNE inhibitors (2018-01-16),
11. 9862706 - Compounds (2018-01-09),
12. 9828382 - Pyrimidinone compounds as human neutrophil elastase inhibitors (2017-11-28),
13. 9802919 - Compounds (2017-10-31),
14. 9763924 - Aminoester derivatives (2017-09-19),
15. 9758521 - Kinase inhibitors (2017-09-12),

Title: Carmelida Capaldi: Pioneering Innovation in the Global Tech Community

Introduction:

Carmelida Capaldi is a visionary inventor based in Parma, Italy, whose passion for innovation and relentless pursuit of excellence have made him a prominent figure in the global tech community. With 28 patents to his name, Carmelida Capaldi continues to inspire future inventors to think outside the box and redefine what is possible in the world of technology.

Latest Patents:

Carmelida Capaldi's latest patents include Kinase inhibitors - Compounds of formula (I) that act as p38 MAPK inhibitors, offering anti-inflammatory properties for treating respiratory diseases. Additionally, his Pyrazolone compounds with human neutrophil elastase inhibitory properties are vital for treating diseases associated with HNE.

Career Highlights:

Working at Chiesi Farmaceutici S.p.A., Carmelida Capaldi has been at the forefront of cutting-edge research and development. His dedication to creating innovative solutions has led to the successful filing of multiple patents that have the potential to revolutionize the medical and pharmaceutical industries.

Collaborations:

Carmelida Capaldi has collaborated with esteemed coworkers such as Elisabetta Armani and Jonathan Mark Sutton, enriching his work with diverse perspectives and expertise. Through teamwork and shared innovation, they have made significant strides in advancing technology and healthcare.

Conclusion:

In conclusion, Carmelida Capaldi's commitment to innovation and his trailblazing inventions have cemented his legacy as a visionary inventor in the global tech community. His work not only pushes the boundaries of what is possible but also serves as an inspiration for generations of inventors to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…